Myung In Pharmaceutical LTD. (KRX:317450)
South Korea flag South Korea · Delayed Price · Currency is KRW
43,300
+3,500 (8.79%)
At close: Jun 29, 2026

KRX:317450 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
606,6301,005,940----
Enterprise Value
85,822532,289----
Last Close Price
41550.0068900.00----
PE Ratio
6.3012.35----
PS Ratio
2.103.50----
PB Ratio
0.761.27----
P/TBV Ratio
0.771.27----
P/FCF Ratio
10.9219.52----
P/OCF Ratio
6.7612.33----
EV/Sales Ratio
0.301.85----
EV/EBITDA Ratio
0.815.15----
EV/EBIT Ratio
0.905.76----
EV/FCF Ratio
1.5410.33----
Debt / Equity Ratio
0.000.000.010.010.010.02
Debt / EBITDA Ratio
0.010.010.030.040.060.07
Debt / FCF Ratio
0.020.030.040.050.090.09
Net Debt / Equity Ratio
-0.66-0.64-0.48-0.39-0.32-0.31
Net Debt / EBITDA Ratio
-4.90-4.91-2.45-1.93-1.58-1.34
Net Debt / FCF Ratio
-9.37-9.87-3.54-2.57-2.39-1.82
Asset Turnover
-0.400.490.490.500.52
Inventory Turnover
-1.821.731.701.741.56
Quick Ratio
7.9712.527.286.375.764.52
Current Ratio
8.8513.938.657.857.155.71
Return on Equity (ROE)
12.90%12.28%13.68%16.63%14.36%16.91%
Return on Assets (ROA)
-8.12%10.51%10.52%10.53%11.41%
Return on Invested Capital (ROIC)
27.14%26.33%25.70%23.54%19.48%21.07%
Return on Capital Employed (ROCE)
12.00%11.60%17.30%17.30%17.40%19.00%
Earnings Yield
14.10%8.09%----
FCF Yield
9.16%5.12%----
Payout Ratio
13.10%13.75%8.15%30.06%19.50%23.43%
Buyback Yield / Dilution
-15.81%-8.23%-0.01%---
Total Shareholder Return
-12.35%-8.23%-0.01%---